Alex Sirois

Alex Sirois

InvestorPlace Contributor

Alex is a freelance contributor to InvestorPlace who provides investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for InvestorPlace is to bring value to the reader.

You can follow Alex on LinkedIn.

Recent Articles

Why Zomedica Is a Great Speculative Play Right Now

By Alex Sirois, InvestorPlace Contributor

ZOM stock makes as much sense as it ever has right now. Truforma's best days are in front of it which is also true of Zomedica shares.

The Reasons to Avoid OCGN Stock Keep Piling Up

By Alex Sirois, InvestorPlace Contributor

OCGN stock got a bump on Phase 3 results but was met with market skepticism following its subsequent strategic moves.

Naked Brands Is Still Worth a Look Following r/WallStreetBets Mania

By Alex Sirois, InvestorPlace Contributor

NAKD stock really deserves a look. It represents a great business case among the social media stocks madness.

7 Risky Stocks That Could Take Off in Strong Companies

By Alex Sirois, InvestorPlace Contributor

Risky stocks are worth your investment dollars if they are strong companies in tough situations. These seven are exactly that.

QuantumScape Still Has a Long Road Ahead of It

By Alex Sirois, InvestorPlace Contributor

QS stock is being received by the markets as if it has zero chance moving forward. Take that news for what it's worth.

Load More